All posts by David Emerson

BAP1 Gene Mutation Linked to Increased Mesothelioma Survival

The median survival for the BAP1 mesothelioma patients was five years, as compared with less than one year for the median survival for those patients without the BAP1 gene. Mesothelioma is a complicated

Continue reading

Umbilical cord blood transplantation for Pediatric Cancer

Umbilical cord blood, a rich source of blood-forming stem cells, has previously been shown to benefit many pediatric cancer patients with leukemia and myelodysplasia and other diseases When I was first

Continue reading

Radiation Before Surgery More Than Doubles Mesothelioma Survival

Results of clinical research that treated mesothelioma with radiation before surgery show the three-year survival rate more than doubled for study participants Conventional oncology is based on FDA approved

Continue reading

Cost-effectivness of Immunotherapy for Metastatic Melanoma-

Consider Evidence-based Integrative Therapies to Enhance the Efficacy of  Melanoma Chemotherapy  While Minimizing Toxicity Based on the Wall Street Journal article linked below, a chemotherapy called

Continue reading
1 138 139 140